10x Genomics (TXG) 因净亏损收窄及营收超预期，股价飙升至历史新高——MSN报道
10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - MSN
#Net Loss#Revenue Beat#Record High#Lower Net#Beat MSN
生命科学资讯
生物技术与制药领域的最新动态
今日10x Genomics（TXG）股价为何上涨 - 金融市场动态
Why 10x Genomics (TXG) Stock Is Trading Up Today - Markets Financial Content
#Markets Financial#Financial Content#Today Markets#Genomics#TXG
沃特世公司推出专为Empower软件设计的带电气溶胶检测器，提升实验室生产力和样品处理能力——MarketScreener
Waters Corporation Boosts Lab Productivity and Sample Throughput with Launch of Its Charged Aerosol Detector Designed for Empower Software - MarketScreener
#Corporation Boosts#Boosts Lab#Lab Productivity#Sample Throughput#Charged Aerosol
罗氏芬奈布替尼在多发性硬化症中展现同类最佳潜力——欧洲药物评论
Roche’s fenebrutinib shows best-in-disease potential in MS - European Pharmaceutical Review
#European Pharmaceutical#Pharmaceutical Review#fenebrutinib shows#Review Roche#Pharmaceutical
10x Genomics公司股票蓄势待发？——每周市场总结与AI增强交易信号
Is 10x Genomics Inc. stock ready for a breakout - Weekly Market Summary & AI Enhanced Trading Signals - newser.com
#Weekly Market#Market Summary#Enhanced Trading#Trading Signals#Genomics
今日10x Genomics (TXG)股价上涨原因解析 - Finviz
Why 10x Genomics (TXG) Stock Is Trading Up Today - Finviz
#Today Finviz#Genomics#TXG#Stock#Trading
10x Genomics（纳斯达克代码：TXG）将于美东时间上午11:20参加Wolfe Research医疗保健大会 - 股票泰坦
10x Genomics (Nasdaq: TXG) to join Wolfe Research Healthcare Conference at 11:20 a.m. ET - Stock Titan
#Wolfe Research#Research Healthcare#Healthcare Conference#join Wolfe#Genomics
10x Genomics (TXG)因净亏损收窄与营收超预期，股价飙升至历史新高——雅虎财经报道
10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - Yahoo Finance
#Net Loss#Revenue Beat#Yahoo Finance#Record High#Lower Net
今日10x Genomics（TXG）股价为何上涨——雅虎财经报道
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
#Yahoo Finance#Today Yahoo#Genomics#TXG#Stock
10x Genomics将出席2025年沃尔夫研究医疗健康大会 - PR Newswire报道
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 - PR Newswire
#Healthcare Conference#Wolfe Research#Research Healthcare#Genomics#Conference
图森新闻：朗扎·亨德森小队长专访——KOLD频道
Captain Lonza Henderson Jr. TUCSON NOW Interview - KOLD
#Lonza Henderson#Captain Lonza#Lonza#Henderson#TUCSON
罗氏凭借三期多发性硬化症试验胜利评估首款BTK抑制剂获批前景——临床试验竞技场
Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena
#Phase III#Clinical Trials#Trials Arena#BTK inhibitor#Roche sizes
罗氏诊断的人工智能应用 - Emerj人工智能研究
Artificial Intelligence at Roche Diagnostics - Emerj Artificial Intelligence Research
#Artificial Intelligence#Intelligence Research#Roche Diagnostics#Emerj Artificial#Research Artificial
10x Genomics股价创52周新高，达17.26美元 - Investing.com报道
10x Genomics stock hits 52-week high at 17.26 USD - Investing.com
#Genomics stock#USD Investing.com#stock hits#Genomics#USD
罗氏报告BTK抑制剂在多发性硬化症三期试验中取得突破，成功超越竞争对手——Fierce Biotech报道
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech
#BTK inhibitor#Fierce Biotech#reports phase#multiple sclerosis#Roche reports
罗氏推出新药，或将颠覆整个多发性硬化症市场——雅虎财经报道
Roche Just Unleashed a Drug That Could Disrupt the Entire MS Market - Yahoo Finance
#Yahoo Finance#Market Yahoo#Finance Roche#Unleashed#Drug
罗氏控股股价今日为何飙升——雅虎财经报道
Why Roche Holding Stock Popped Today - Yahoo Finance
#Roche Holding#Holding Stock#Stock Popped#Popped Today#Yahoo Finance
罗氏实验性多发性硬化药物在两项关键试验中一项达到主要目标——路透社
Roche's experimental MS drug hits main goal in one of two key trials - Reuters
#Roche experimental#drug hits#hits main#main goal#key trials
罗氏多发性硬化症片剂在后期研究中取得成效——BioPharma Dive
Roche’s MS tablet scores in late-stage studies - BioPharma Dive
#BioPharma Dive#tablet scores#Dive Roche#late-stage studies#Dive
罗氏竞争对手因多发性硬化症治疗“史无前例”结果股价暴跌——投资者商业日报
Roche Rival Plunges On 'Unprecedented' Results In MS Treatment - Investor's Business Daily
#Rival Plunges#Investor Business#Business Daily#Roche Rival#Treatment Investor